Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1Thyroid Cancer, Papillary 1Sarcoma 1Radiation Injuries 1Patient Satisfaction 1Patient Acceptance of Health Care 1Neoplasms 1Breast Neoplasms 1

Interventions

Radiotherapy 16Amifostine 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Paclitaxel 4Donepezil 4sargramostim 3Radiosurgery 3Low-Level Light Therapy 3Filgrastim 3Etoposide 3Carboplatin 3Surveys and Questionnaires 2Radiation 2Magnetic Resonance Spectroscopy 2Esophagectomy 2Diet Therapy 2Chemotherapy, Adjuvant 2Brachytherapy 2Bevacizumab 2olaparib 1ethanethiol 1delta 24-sterol reductase 1cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vitamin E 1Vincristine 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Radiation Injuries × delta 24-sterol reductase × Clear all
NCT04590976 2023-02-08

IP5-MATTER

Imperial College London

Completed
320 enrolled
Genitourinary

Patient Acceptance of Health Care, Radiation Injuries, Urologic Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡